Chirantan Chatterjee

980 total citations
51 papers, 532 citations indexed

About

Chirantan Chatterjee is a scholar working on Economics and Econometrics, Management of Technology and Innovation and Strategy and Management. According to data from OpenAlex, Chirantan Chatterjee has authored 51 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Economics and Econometrics, 16 papers in Management of Technology and Innovation and 6 papers in Strategy and Management. Recurrent topics in Chirantan Chatterjee's work include Intellectual Property and Patents (15 papers), Pharmaceutical Economics and Policy (14 papers) and Firm Innovation and Growth (10 papers). Chirantan Chatterjee is often cited by papers focused on Intellectual Property and Patents (15 papers), Pharmaceutical Economics and Policy (14 papers) and Firm Innovation and Growth (10 papers). Chirantan Chatterjee collaborates with scholars based in India, United States and United Kingdom. Chirantan Chatterjee's co-authors include Pavel Chakraborty, Arzi Adbi, Vasanthi Srinivasan, Anant Mishra, Enrico Pennings, Anindya S. Chakrabarti, Adrija Majumdar, Sourav Bhattacharya, Matthew J. Higgins and Neeraj Sood and has published in prestigious journals such as SHILAP Revista de lepidopterología, Management Science and Research Policy.

In The Last Decade

Chirantan Chatterjee

44 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chirantan Chatterjee India 11 369 139 137 73 43 51 532
Shabir Hyder Pakistan 12 173 0.5× 153 1.1× 108 0.8× 77 1.1× 48 1.1× 32 567
Syed Ghulam Meran Shah China 15 253 0.7× 211 1.5× 253 1.8× 34 0.5× 15 0.3× 22 740
Cynthia Van Hulle Belgium 19 784 2.1× 101 0.7× 243 1.8× 43 0.6× 43 1.0× 82 1.4k
William Chongyang Zhou China 12 254 0.7× 48 0.3× 228 1.7× 79 1.1× 17 0.4× 23 451
Mrinalini Srivastava India 12 247 0.7× 65 0.5× 129 0.9× 38 0.5× 25 0.6× 14 502
Brent McKnight Canada 8 161 0.4× 89 0.6× 288 2.1× 95 1.3× 21 0.5× 16 576
Mubbasher Munir Pakistan 12 224 0.6× 41 0.3× 60 0.4× 26 0.4× 92 2.1× 30 425
Q Lê Vietnam 13 261 0.7× 44 0.3× 146 1.1× 16 0.2× 40 0.9× 55 504
Tang Meirun China 7 251 0.7× 276 2.0× 196 1.4× 70 1.0× 92 2.1× 10 521
Juying Zeng China 12 276 0.7× 121 0.9× 121 0.9× 80 1.1× 27 0.6× 28 468

Countries citing papers authored by Chirantan Chatterjee

Since Specialization
Citations

This map shows the geographic impact of Chirantan Chatterjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chirantan Chatterjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chirantan Chatterjee more than expected).

Fields of papers citing papers by Chirantan Chatterjee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chirantan Chatterjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chirantan Chatterjee. The network helps show where Chirantan Chatterjee may publish in the future.

Co-authorship network of co-authors of Chirantan Chatterjee

This figure shows the co-authorship network connecting the top 25 collaborators of Chirantan Chatterjee. A scholar is included among the top collaborators of Chirantan Chatterjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chirantan Chatterjee. Chirantan Chatterjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chatterjee, Chirantan, et al.. (2024). Do Stronger IPR Incentivize Female Participation in Innovation? Evidence from Chinese AI Patents. SSRN Electronic Journal.
2.
Chakrabarti, Anindya S., et al.. (2023). Movies, stigma and choice: Evidence from the pharmaceutical industry. Health Economics. 32(5). 1019–1039.
3.
Dukes, Anthony, et al.. (2023). The Dynamics of Private Trademark Enforcement: The Case of Indian Pharmaceuticals. Academy of Management Proceedings. 2023(1). 1 indexed citations
4.
Chatterjee, Chirantan, et al.. (2023). Human mediation leads to higher compliance in digital mental health: field evidence from India. 2. 1 indexed citations
5.
Chatterjee, Chirantan, et al.. (2022). Equilibrium Effects of Pharmaceutical Bundling: Evidence from India. SSRN Electronic Journal.
6.
Chakrabarti, Anindya S., et al.. (2022). Pandemics and technology engagement: New evidence from m‐Health intervention during COVID‐19 in India. Review of Development Economics. 26(4). 2184–2217. 6 indexed citations
7.
Chatterjee, Chirantan, et al.. (2021). Fight or Surrender to Counterfeiters: Litigation as a Response to Trademark Infringement. SSRN Electronic Journal. 1 indexed citations
8.
Chatterjee, Chirantan, et al.. (2021). How Does Regulation Impact Strategic Repositioning by Firms Across Submarkets? Evidence from the Indian Pharmaceutical Industry. Strategy Science. 6(3). 209–227. 4 indexed citations
9.
Deo, Sarang, et al.. (2020). Did India’s Price Control Policy for Coronary Stents Create Unintended Consequences?. SSRN Electronic Journal.
10.
Higgins, Matthew J., et al.. (2020). Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling. Research Policy. 50(1). 104126–104126. 3 indexed citations
11.
Deo, Sarang, et al.. (2019). Did India's price control policy for coronary stents create unintended consequences?. Social Science & Medicine. 246. 112737–112737. 6 indexed citations
12.
Chatterjee, Chirantan, et al.. (2019). From courts to markets: New evidence on enforcement of pharmaceutical bans in India. Social Science & Medicine. 237. 112480–112480. 1 indexed citations
13.
Adbi, Arzi, et al.. (2018). When the Big One Came: A Natural Experiment on Demand Shock and Market Structure in India's Influenza Vaccine Markets. Production and Operations Management. 28(4). 810–832. 20 indexed citations
14.
Adbi, Arzi, Nafis Faizi, & Chirantan Chatterjee. (2017). Analysing the lazy mother argument inspired by the Maggi controversy evidence from junk food intake in India.. Economic and political weekly. 52(28). 2 indexed citations
15.
Chatterjee, Chirantan, et al.. (2016). Mitigating regulatory impact: the case of partial price controls on metformin in India. Health Policy and Planning. 32(2). czw109–czw109. 17 indexed citations
16.
Chatterjee, Chirantan, et al.. (2015). The consumer welfare implications of governmental policies and firm strategy in markets for medicines. Journal of Health Economics. 44. 255–273. 23 indexed citations
17.
Branstetter, Lee, Chirantan Chatterjee, & Matthew J. Higgins. (2014). Starving (or Fattening) the Golden Goose?: Generic Entry and the Incentives for Early-Stage Pharmaceutical Innovation. SSRN Electronic Journal. 7 indexed citations
18.
Chatterjee, Chirantan, et al.. (2013). Crocin or paracetamol what should the doctor prescribe. Economic and political weekly. 48(41). 20–22. 4 indexed citations
19.
Chatterjee, Chirantan. (2007). Fundamental Patent Reform and the Private Returns to R&D - The Case of Indian Pharmaceuticals. 3 indexed citations
20.
Chatterjee, Chirantan, et al.. (2006). Use of Medical Library by Medical Students and Teachers in Medical Colleges of Kolkata. SHILAP Revista de lepidopterología. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shabir Hyder Breakdown of academic impact, for papers by Syed Ghulam Meran Shah Breakdown of academic impact, for papers by Cynthia Van Hulle Breakdown of academic impact, for papers by William Chongyang Zhou Breakdown of academic impact, for papers by Mrinalini Srivastava Breakdown of academic impact, for papers by Brent McKnight Breakdown of academic impact, for papers by Mubbasher Munir Breakdown of academic impact, for papers by Q Lê Breakdown of academic impact, for papers by Tang Meirun Breakdown of academic impact, for papers by Juying Zeng
Rankless by CCL
2026